naringenin has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Liu, L; Wang, Q; Zhou, T | 1 |
| Afshin-Majd, S; Baluchnejadmojarad, T; Khajevand-Khazaei, MR; Motevalizadeh, SA; Roghani, M; Rohani, M; Ziaee, P | 1 |
| Ahmad, A; Ahmed, ME; Ishrat, T; Islam, F; Khan, A; Khan, MB; Khan, MM; Tabassum, R; Vaibhav, K | 1 |
3 other study(ies) available for naringenin and Cognition Disorders
| Article | Year |
|---|---|
Naringenin alleviates cognition deficits in high-fat diet-fed SAMP8 mice.
Topics: Animals; Cognition; Cognition Disorders; Cognitive Dysfunction; Diet, High-Fat; Flavanones; Mice; Rats | 2020 |
Naringenin ameliorates learning and memory impairment following systemic lipopolysaccharide challenge in the rat.
Topics: Acetylcholinesterase; Animals; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Flavanones; Hippocampus; Humans; Inflammation; Lipopolysaccharides; Male; Maze Learning; Memory, Short-Term; Neuroprotective Agents; Oxidative Stress; Rats; Rats, Wistar; Spatial Memory | 2018 |
Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model.
Topics: Alzheimer Disease; Animals; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Flavanones; Injections, Intraventricular; Male; Rats; Rats, Wistar; Streptozocin | 2012 |